On 25 April, 2018, ERS will join a number of public health organisations to recognise the first European Alpha-1 Awareness Day, organised by Alpha-1 Global.
The awareness day aims to increase public understanding of Alpha-1 Antitrypsin Deficiency (AATD), a recessive inherited disorder that affects 1 in 2-5,000 people in Europe.
AATD is most common in individuals of Northern European and Iberian descent, and the most common lung disease that people with AATD are likely to develop is chronic obstructive pulmonary disease (COPD).
Despite its prevalence in Europe, patients and healthcare providers continue to be poorly informed about the disorder; it is estimated that only 5% of people with AATD have been diagnosed, highlighting the widespread lack of understanding about this rare condition.
To mark the day, we’ve gathered together a range of articles, statements and editorials published by ERS on the topic of alpha-1, in addition to interactive e-learning materials to refresh your knowledge of the condition.